DNA Testing Kits in AI Search: The Biggest AI Visibility Problems and How We'd Fix Them

Companies covered: 23andMe, tellmeGen, Living DNA, AncestryDNA, CRI Genetics, FamilyTreeDNA, Health Nucleus, MyHeritage DNA, Nebula Genomics, African Ancestry

Answer Capsule

The November 2026 DNA Testing Kits benchmark compares 10 companies across 561 AI answers that met its inclusion rules. AncestryDNA recorded 560 mentions and 349 recommendations (62.21% of the answers). Being mentioned means appearing in an answer; being recommended means receiving an affirmative endorsement.

We examine each company, compare the available monthly results, and set out a five-step plan for improving the information AI systems can draw on. The work starts with measuring visibility and checking conflicting claims, then moves to company pages, relevant publishers and buyer questions. The cited pages need review before any correction request, and the research does not establish what caused recommendation differences or promise future gains.

Executive industry diagnosis

Questions This Section Answers

• What does the DNA Testing Kits benchmark show about mentions, recommendations and placement?

The peer set splits into a clear top tier and a long tail. AncestryDNA and 23andMe appear in nearly every answer, MyHeritage DNA and FamilyTreeDNA follow at a distance, and the remaining brands surface far less often. Reach, not endorsement, is what separates the leaders from the rest.

Endorsement strength does not simply follow mention volume. AncestryDNA pairs its wide presence with frequent recommendations and first-place placements, while 23andMe and MyHeritage DNA are recommended often but rarely named first. FamilyTreeDNA and Living DNA show a similar gap at smaller scale.

The practical implication is that visibility and preference are separate problems. A brand can be named in most answers yet still lose the top slot. Work should target the specific questions where a company is mentioned but not endorsed, rather than chasing raw mention growth.

What changed since last month

Questions This Section Answers

• What changed across the usable monthly DNA Testing Kits snapshots?

Across the selected monthly samples, recommendation counts for the leading brands moved noticeably between October and November, while mention counts changed far less. The samples differ month to month, so these are separate snapshots rather than a like-for-like trend.

The observed movement should be read as a change in recorded results, not as evidence about why counts or rates shifted. A smaller answer total does not by itself explain a lower recommendation count. Treat the history as directional context and rely on the current month for decisions.

Company-by-company findings

23andMe

Questions This Section Answers

• What measured visibility pattern and review priority does 23andMe have in DNA Testing Kits?

23andMe recorded 544 mentions (96.97%) and 275 recommendations (49.02%) across 561 answers included in the benchmark. Top 3 placements numbered 213; first-place recommendations numbered 5. Framing among its mentions was 296 positive, 239 neutral and 9 negative.

From October 2026 to November 2026, 23andMe's mention count fell from 547 to 544, while its recommendation count fell from 379 to 275. The recommendation rate was 67.32% and 49.02% respectively.

AI answers contained 41 conflicting claims about 23andMe: 17 critical, 11 high, 13 medium, 0 low. Of these, 28 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://customercare.23andme.com/hc/en-us/articles/360044957274-How-Accurate-Is-23andMe.

Selected third-party review candidate: https://yahoo.com/lifestyle/articles/best-dna-test-2025-035100700.html.

23andMe is named in almost every answer and recommended in roughly half, but first-place placement is rare. That gap between broad reach and top-slot preference is the real opportunity, not more mentions.

We would propose a conditional review of the accuracy page and the selected third-party review, checking current primary sources before any edit. A buyer-question brief on accuracy claims would help, with fact checks on the conflicting business-status and FDA claims kept separate from page work.

tellmeGen

Questions This Section Answers

• What measured visibility pattern and review priority does tellmeGen have in DNA Testing Kits?

tellmeGen recorded 22 mentions (3.92%) and 7 recommendations (1.25%) across 561 answers included in the benchmark. Top 3 placements numbered 3; first-place recommendations numbered 1. Framing among its mentions was 8 positive, 14 neutral and 0 negative.

From October 2026 to November 2026, tellmeGen's mention count rose from 12 to 22, while its recommendation count rose from 3 to 7. The recommendation rate was 0.53% and 1.25% respectively.

AI answers contained 0 conflicting claims about tellmeGen: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://tellmegen.com/en/upload-raw-data.

Selected third-party review candidate: https://walmart.com/ip/tellmeGen-DNA-Test-Advanced-400-Health-Traits-Wellness-Ancestry-Reports-All-Fees-Included/898323403?selectedSellerId=101104697&wmlspartner=wlpa.

tellmeGen has modest reach and few recommendations, with no negative framing recorded. Its presence rose between the two selected months, but the samples differ, so this is not a like-for-like gain.

With no conflicting claims recorded, the priority is evidence verification rather than correction. We would propose a page brief for the raw-data upload page and a review of the selected retail listing, confirming current product facts from primary sources before recommending any change.

Living DNA

Questions This Section Answers

• What measured visibility pattern and review priority does Living DNA have in DNA Testing Kits?

Living DNA recorded 183 mentions (32.62%) and 73 recommendations (13.01%) across 561 answers included in the benchmark. Top 3 placements numbered 9; first-place recommendations numbered 1. Framing among its mentions was 88 positive, 95 neutral and 0 negative.

From October 2026 to November 2026, Living DNA's mention count rose from 148 to 183, while its recommendation count fell from 97 to 73. The recommendation rate was 17.23% and 13.01% respectively.

AI answers contained 2 conflicting claims about Living DNA: 0 critical, 0 high, 2 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://livingdna.com/kit/ancestry-dna-test.

Selected third-party review candidate: https://genealogyexplained.com/living-dna-review/.

Living DNA is mentioned in about a third of answers but recommended far less often, and first-place placement is rare. Its reach is real; turning that presence into affirmative endorsement is the challenge.

Two price conflicts were recorded at medium severity. We would propose a fact-check of current kit pricing against primary sources, then a page brief for the ancestry kit page and a review of the third-party review, treating any correction as conditional on verification.

AncestryDNA

Questions This Section Answers

• What measured visibility pattern and review priority does AncestryDNA have in DNA Testing Kits?

AncestryDNA recorded 560 mentions (99.82%) and 349 recommendations (62.21%) across 561 answers included in the benchmark. Top 3 placements numbered 317; first-place recommendations numbered 305. Framing among its mentions was 369 positive, 188 neutral and 3 negative.

From October 2026 to November 2026, AncestryDNA's mention count fell from 561 to 560, while its recommendation count fell from 412 to 349. The recommendation rate was 73.18% and 62.21% respectively.

AI answers contained 129 conflicting claims about AncestryDNA: 0 critical, 1 high, 46 medium, 82 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://ancestry.com/dna.

Selected third-party review candidate: https://yourdnaguide.com/ydgblog/best-dna-tests-ancestry.

AncestryDNA leads on both reach and endorsement, and it holds first place in most answers. Its advantage is preference as much as presence, which makes defending the top slot the priority rather than expanding coverage.

Many conflicting claims were recorded, mostly low severity, with database size the recurring theme. We would propose a fact-check of current database figures against primary sources, then a page brief for the main DNA page, keeping any correction conditional on verification.

CRI Genetics

Questions This Section Answers

• What measured visibility pattern and review priority does CRI Genetics have in DNA Testing Kits?

CRI Genetics recorded 17 mentions (3.03%) and 4 recommendations (0.71%) across 561 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 5 positive, 11 neutral and 1 negative.

From October 2026 to November 2026, CRI Genetics' mention count rose from 13 to 17, while its recommendation count rose from 3 to 4. The recommendation rate was 0.53% and 0.71% respectively.

AI answers contained 0 conflicting claims about CRI Genetics: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://crigenetics.com/blog/how-much-does-a-dna-test-cost-and-how-long-do-they-take.html.

Selected third-party review candidate: https://xcode.life/genetics/how-much-is-a-dna-test/.

CRI Genetics has low reach and few recommendations, with no top-three or first-place placements recorded. It appears mainly as an alternative in comparison-style questions rather than as a leading pick.

No conflicting claims were recorded, so the starting point is understanding where it does surface. We would propose a page brief for the cost article and a review of the selected price comparison source, verifying current facts before any request or edit.

FamilyTreeDNA

Questions This Section Answers

• What measured visibility pattern and review priority does FamilyTreeDNA have in DNA Testing Kits?

FamilyTreeDNA recorded 388 mentions (69.16%) and 205 recommendations (36.54%) across 561 answers included in the benchmark. Top 3 placements numbered 100; first-place recommendations numbered 3. Framing among its mentions was 221 positive, 167 neutral and 0 negative.

From October 2026 to November 2026, FamilyTreeDNA's mention count fell from 426 to 388, while its recommendation count fell from 325 to 205. The recommendation rate was 57.73% and 36.54% respectively.

AI answers contained 4 conflicting claims about FamilyTreeDNA: 0 critical, 0 high, 3 medium, 1 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://familytreedna.com/.

Selected third-party review candidate: https://yourdnaguide.com/ydgblog/best-dna-tests-ancestry.

FamilyTreeDNA is mentioned in most answers and recommended in over a third, but first-place placement is rare. Strong reach paired with weak top-slot preference is the defining pattern.

Several conflicts concern raw-data upload fees. We would propose a fact-check of current upload and matching terms against primary sources, then a page brief for the main site and a review of the third-party guide, with corrections conditional on verification.

Health Nucleus

Questions This Section Answers

• What measured visibility pattern and review priority does Health Nucleus have in DNA Testing Kits?

Health Nucleus recorded 0 mentions (0.00%) and 0 recommendations (0.00%) across 561 answers included in the benchmark. Top 3 placements numbered 0; first-place recommendations numbered 0. Framing among its mentions was 0 positive, 0 neutral and 0 negative.

From October 2026 to November 2026, Health Nucleus' mention count stayed at 0, while its recommendation count stayed at 0. The recommendation rate was 0.00% and 0.00% respectively.

AI answers contained 0 conflicting claims about Health Nucleus: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

No results are available for this part of the analysis.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Health Nucleus recorded no mentions and no recommendations in the current sample, and the same in the prior month. An observed zero is a genuine absence in these answers, not a measurement gap.

The first task is understanding why the brand does not surface at all before setting any target. We would propose a scoping review of how the company is described and positioned, confirming basic facts from primary sources before deciding whether any content work is warranted.

MyHeritage DNA

Questions This Section Answers

• What measured visibility pattern and review priority does MyHeritage DNA have in DNA Testing Kits?

MyHeritage DNA recorded 442 mentions (78.79%) and 243 recommendations (43.32%) across 561 answers included in the benchmark. Top 3 placements numbered 177; first-place recommendations numbered 9. Framing among its mentions was 262 positive, 176 neutral and 4 negative.

From October 2026 to November 2026, MyHeritage DNA's mention count fell from 449 to 442, while its recommendation count fell from 335 to 243. The recommendation rate was 59.50% and 43.32% respectively.

AI answers contained 17 conflicting claims about MyHeritage DNA: 0 critical, 1 high, 11 medium, 5 low. Of these, 1 was rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://myheritage.com/dna.

Selected third-party review candidate: https://yourdnaguide.com/ydgblog/best-dna-tests-ancestry.

MyHeritage DNA is mentioned in most answers and recommended in a large share, yet first-place placement is rare. Like its closest peers, it has reach without consistent top-slot preference.

Recorded conflicts touch database size and kit price, one at high severity. We would propose a fact-check of current pricing and database figures against primary sources, then a page brief for the main DNA page and a review of the third-party guide, with edits conditional on verification.

Nebula Genomics

Questions This Section Answers

• What measured visibility pattern and review priority does Nebula Genomics have in DNA Testing Kits?

Nebula Genomics recorded 154 mentions (27.45%) and 95 recommendations (16.93%) across 561 answers included in the benchmark. Top 3 placements numbered 30; first-place recommendations numbered 3. Framing among its mentions was 102 positive, 52 neutral and 0 negative.

From October 2026 to November 2026, Nebula Genomics' mention count rose from 126 to 154, while its recommendation count rose from 93 to 95. The recommendation rate was 16.52% and 16.93% respectively.

AI answers contained 3 conflicting claims about Nebula Genomics: 2 critical, 1 high, 0 medium, 0 low. Of these, 3 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://nebula.org/.

Selected third-party review candidate: https://guidetogenetics.com/best-dna-tests-overall/.

Nebula Genomics has moderate reach and a smaller recommendation share, with few top-three and first-place placements. Its mentions are mostly positive in framing, but endorsement is limited.

The most serious issue is a cluster of critical and high-severity conflicts about whether the company is still operating. We would propose resolving business status from primary sources first, then a page brief for the main site and a review of the comparison guide, holding any correction until status is confirmed.

African Ancestry

Questions This Section Answers

• What measured visibility pattern and review priority does African Ancestry have in DNA Testing Kits?

African Ancestry recorded 30 mentions (5.35%) and 4 recommendations (0.71%) across 561 answers included in the benchmark. Top 3 placements numbered 3; first-place recommendations numbered 1. Framing among its mentions was 4 positive, 26 neutral and 0 negative.

From October 2026 to November 2026, African Ancestry's mention count rose from 21 to 30, while its recommendation count fell from 14 to 4. The recommendation rate was 2.49% and 0.71% respectively.

AI answers contained 0 conflicting claims about African Ancestry: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.

No results are available for this part of the analysis.

Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.

These are recorded answer observations, not search volume, verified demand, or proof of missing website content.

Selected owned-page review candidate: https://africanancestry.com/.

Selected third-party review candidate: https://genometesting.org/blog/best-dna-test-ancestry-2026.html.

African Ancestry has low reach and very few recommendations, and its mentions are mostly neutral in framing. It surfaces in heritage-focused questions rather than broad comparisons.

Its recommendation count fell between the two selected months while mentions rose, though the samples differ and this is not a like-for-like comparison. We would propose a page brief for the main site and a review of the heritage-test source, verifying current facts before any request.

The CiteWorks five-step improvement plan

Step 1. Establish the baseline

Questions This Section Answers

• What should the agency deliver when it works to establish the baseline for DNA Testing Kits?

We would build a cohort scorecard that records each company's mentions, recommendations and placements against the same answer set, with the comparability limits noted alongside. Every entry gets an owner, an evidence requirement and a review status so future months can be read consistently.

Step 2. Verify disputed facts

Questions This Section Answers

• What should the agency deliver when it works to verify disputed facts for DNA Testing Kits?

AI answers contained 196 conflicting claims across 6 companies. Another 0 possible conflicts were excluded because their company matches were uncertain. The conflicting claims need fact-checking before any corrections are proposed.

Before any correction is proposed, disputed claims need resolution against current primary sources. We would work through the recorded conflicts company by company, confirming entity, date and source, and separating confirmed issues from apparent conflicts that different dates may explain. Ambiguous company matches stay out of the queue.

Step 3. Review owned pages

Questions This Section Answers

• What should the agency deliver when it works to review owned pages for DNA Testing Kits?

Each supplied owned-page candidate gets a page brief describing what to verify and what, if anything, to change. Briefs are grounded in current page contents and primary sources, not in AI claims, and no edit proceeds until the underlying facts are confirmed.

Step 4. Review third-party sources

Questions This Section Answers

• What should the agency deliver when it works to review third-party sources for DNA Testing Kits?

For the selected third-party sources, we would prepare evidence-backed review packages: what the page currently says, what the primary sources support, and a specific, polite request where a discrepancy is confirmed. A citation alone does not show the source influenced an answer, so requests stay grounded in verified content.

Step 5. Address buyer questions and measure again

Questions This Section Answers

• What should the agency deliver when it works to address buyer questions and measure again for DNA Testing Kits?

Observed buyer questions become content briefs covering accuracy, pricing and alternatives, written for the questions people actually ask. Delivered work is tracked separately from answer outcomes, and a fresh scorecard records any movement without claiming that the work caused it.

Third-party authority and citation opportunities

Questions This Section Answers

• Which cited publisher pages support targeted source review in DNA Testing Kits?

These pages are candidates for review, not confirmed errors. Citation appearances are counted across the captured answers and are not added again for each company.

The publisher list should be prioritized by how often each page is cited and how many of the tracked companies it covers. The genealogy guide and the wirecutter review stand out on citation appearances, making them the natural first reviews, with the health-testing and video sources next.

Citation frequency is not evidence of influence or error. Before any request, we would verify what each page currently says against primary sources, then prepare a targeted review package only where a discrepancy is confirmed.

What we'd prioritize first

The first priority is the baseline scorecard and a scoped fact-review register, so every disputed claim has an owner and an evidence requirement. Alongside it, a shortlist of pages and sources keeps the work focused on the highest-citation candidates.

The second priority is resolving the most serious conflicts, particularly the business-status claims around Nebula Genomics and 23andMe, since these affect whether a brand is presented as a live option at all. Approved page briefs and justified publisher requests follow once facts are confirmed.

The third priority is buyer-question content and a fresh scorecard, with completed work recorded separately from measured answer outcomes and comparability limits stated plainly.

Methodology and conclusion

Questions This Section Answers

• What do the DNA Testing Kits sample and source-review limits allow us to conclude?

This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 561 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.

An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.

The wider citation analysis covers 800 captured answers and 5891 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.

Monthly sample coverage:

The answer samples differ between months. These comparisons show how the recorded results changed; they do not establish why they changed.

This reading treats the monthly results as separate selected samples. The answer totals differ between months, and the comparisons show how recorded results changed without establishing why. Recommendation requires both endorsement and positive wording, and placements sit inside recommendations rather than adding to them.

The proposed work is a sequence of verification and content steps, not a promise of improved placement. Current page contents and disputed company claims still need independent checking before any correction is proposed, and confirmed edits, no-change decisions and requests should be recorded separately from answer outcomes.